Inhibitor patients present a difficult clinical challenge

Patients with inhibitors are at greater risk for complications that can disrupt their lives. They experience increased risk of uncontrolled bleeds and are more difficult to manage.

Inhibitors result in reduced levels of health-related quality of life1

Reference

  1. 1. Gringeri A, Mantovani LG, Scalone L, Mannuccio Mannucci P. Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group. Blood. 2003:102(7):2358-2363.

Integral to inhibitor management

Learn how FEIBA is integral to the management of patients with inhibitors. Read more

Prophylaxis case studies

Learn how FEIBA prophylaxis reduced bleeding episodes in multiple patients. Read more

Watch: How to reconstitute FEIBA

View this video to learn how reconstituting FEIBA is as easy as 1, 2, 3. Watch video